Rachael Nokes
2022
In 2022, Rachael Nokes earned a total compensation of $1.1M as Chief Financial Officer at scPharmaceuticals, a 46% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $121,500 |
|---|---|
| Option Awards | $554,354 |
| Salary | $362,284 |
| Other | $12,670 |
| Total | $1,050,808 |
Nokes received $554.4K in option awards, accounting for 53% of the total pay in 2022.
Nokes also received $121.5K in non-equity incentive plan, $362.3K in salary and $12.7K in other compensation.
Rankings
In 2022, Rachael Nokes' compensation ranked 2,912th out of 5,672 executives tracked by ExecPay. In other words, Nokes earned more than 48.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,912 out of 5,672 | 49th |
Division Manufacturing | 1,628 out of 3,081 | 47th |
Major group Chemicals And Allied Products | 760 out of 1,396 | 46th |
Industry group Drugs | 709 out of 1,297 | 45th |
Industry Pharmaceutical Preparations | 512 out of 940 | 46th |
Source: SEC filing on April 27, 2023.
Nokes' colleagues
We found one more compensation record of an executive who worked with Rachael Nokes at scPharmaceuticals in 2022.
2022
John Tucker
scPharmaceuticals
Chief Executive Officer
News
scPharmaceuticals CEO John Tucker's 2022 pay slips 14% to $1.6M
April 27, 2023
scPharmaceuticals CEO John Tucker's 2021 pay rises 7% to $1.9M
April 28, 2022
scPharmaceuticals CEO John Tucker's 2020 pay jumps 40% to $1.7M
April 27, 2021
scPharmaceuticals CEO John Tucker's 2019 pay slips 17% to $1.2M
April 27, 2020